{"id":"https://openalex.org/W2584540372","doi":null,"title":"Selective Episcleral Drug Delivery of Neuroprotective Drugs. Toxicokinetics of a Neuroprotective Estradiol Analog and Implications for Treatment of Traumatic and Neurodegenerative Ocular Conditions","display_name":"Selective Episcleral Drug Delivery of Neuroprotective Drugs. Toxicokinetics of a Neuroprotective Estradiol Analog and Implications for Treatment of Traumatic and Neurodegenerative Ocular Conditions","alternate_titles":[],"publication_year":2016,"publication_date":"2016-09-26","ids":{"openalex":"https://openalex.org/W2584540372","mag":"2584540372"},"language":"en","primary_location":{"id":"mag:2584540372","doi":null,"is_oa":true,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2561699","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2584540372"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://iovs.arvojournals.org/article.aspx?articleid=2561699","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002994581","display_name":"Jacques Manders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160150","display_name":"3T Ophthalmics (United States)","ror":"https://ror.org/04q4jqq66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160150"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacques Manders","raw_affiliation_strings":["3t Ophthalmics, Irvine, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3t Ophthalmics, Irvine, California, United States","institution_ids":["https://openalex.org/I4210160150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069769114","display_name":"Jonathan Moreno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160150","display_name":"3T Ophthalmics (United States)","ror":"https://ror.org/04q4jqq66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160150"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Moreno","raw_affiliation_strings":["3t Ophthalmics, Irvine, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3t Ophthalmics, Irvine, California, United States","institution_ids":["https://openalex.org/I4210160150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028544661","display_name":"robert brito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160150","display_name":"3T Ophthalmics (United States)","ror":"https://ror.org/04q4jqq66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160150"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"robert brito","raw_affiliation_strings":["3t Ophthalmics, Irvine, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3t Ophthalmics, Irvine, California, United States","institution_ids":["https://openalex.org/I4210160150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091841380","display_name":"Monica C Vargas-Dougherty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160150","display_name":"3T Ophthalmics (United States)","ror":"https://ror.org/04q4jqq66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160150"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monica C Vargas-Dougherty","raw_affiliation_strings":["3t Ophthalmics, Irvine, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3t Ophthalmics, Irvine, California, United States","institution_ids":["https://openalex.org/I4210160150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049412878","display_name":"Pamela P. Ko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160150","display_name":"3T Ophthalmics (United States)","ror":"https://ror.org/04q4jqq66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160150"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela P. Ko","raw_affiliation_strings":["3t Ophthalmics, Irvine, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3t Ophthalmics, Irvine, California, United States","institution_ids":["https://openalex.org/I4210160150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018400508","display_name":"Claudia Mendes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160150","display_name":"3T Ophthalmics (United States)","ror":"https://ror.org/04q4jqq66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160150"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudia Mendes","raw_affiliation_strings":["3t Ophthalmics, Irvine, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3t Ophthalmics, Irvine, California, United States","institution_ids":["https://openalex.org/I4210160150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041773788","display_name":"Guilherme Costa Matsutani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160150","display_name":"3T Ophthalmics (United States)","ror":"https://ror.org/04q4jqq66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160150"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guilherme Costa Matsutani","raw_affiliation_strings":["3t Ophthalmics, Irvine, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3t Ophthalmics, Irvine, California, United States","institution_ids":["https://openalex.org/I4210160150"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108156982","display_name":"Ricardo A P De Carvalho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160150","display_name":"3T Ophthalmics (United States)","ror":"https://ror.org/04q4jqq66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160150"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ricardo A P De Carvalho","raw_affiliation_strings":["3t Ophthalmics, Irvine, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3t Ophthalmics, Irvine, California, United States","institution_ids":["https://openalex.org/I4210160150"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210160150"],"apc_list":{"value":1850,"currency":"USD","value_usd":1850},"apc_paid":{"value":1850,"currency":"USD","value_usd":1850},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"57","issue":"12","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.7329000234603882,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.7329000234603882,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.19529999792575836,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.013500000350177288,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroprotective-agents","display_name":"neuroprotective agents","score":0.9480000138282776},{"id":"https://openalex.org/keywords/estradiol-analogs","display_name":"estradiol analogs","score":0.906000018119812},{"id":"https://openalex.org/keywords/toxicokinetics","display_name":"toxicokinetics","score":0.9729999899864197},{"id":"https://openalex.org/keywords/ocular-drug-delivery","display_name":"ocular drug delivery","score":0.6190000176429749},{"id":"https://openalex.org/keywords/ocular-trauma","display_name":"ocular trauma","score":0.7870000004768372},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.6690000295639038}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.9168214797973633},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6248109936714172},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5834673643112183},{"id":"https://openalex.org/C195289149","wikidata":"https://www.wikidata.org/wiki/Q2256694","display_name":"Toxicokinetics","level":3,"score":0.5818674564361572},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5379588603973389},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.1515485942363739}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2584540372","doi":null,"is_oa":true,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2561699","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null}],"best_oa_location":{"id":"mag:2584540372","doi":null,"is_oa":true,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2561699","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W839499890","https://openalex.org/W3116733283","https://openalex.org/W2992286881","https://openalex.org/W1135911799","https://openalex.org/W2992693424","https://openalex.org/W2917748433","https://openalex.org/W1180553063","https://openalex.org/W999684221","https://openalex.org/W3042648005","https://openalex.org/W2739249415"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2584540372","counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-10T00:00:00"}
